Search research articles
Contact Us
Filters
Showing results (31-40 of 75) with videos related to
Page
of 8
Sort By:
Journal of Medicinal Chemistry
|
February 26, 2010
Dopamine receptor ligands. Part 18: (1) modification of the structural skeleton of indolobenzazecine-type dopamine receptor antagonists
Dina Robaa, Christoph Enzensperger, Shams El Din Abul Azm, et al.
Molecules (Basel, Switzerland)
|
April 30, 2021
Binding Free Energy (BFE) Calculations and Quantitative Structure-Activity Relationship (QSAR) Analysis of <i>Schistosoma mansoni</i> Histone Deacetylase 8 (<i>sm</i>HDAC8) Inhibitors
Conrad V Simoben, Ehab Ghazy, Patrik Zeyen, et al.
Molecules (Basel, Switzerland)
|
February 13, 2025
Synthesis and Antimycobacterial Assays of Some New Ethambutol Analogs
Rana Abdelaziz, Mthandazo Dube, Lea Mann, et al.
Pharmaceuticals (Basel, Switzerland)
|
July 29, 2023
Application of Ligand- and Structure-Based Prediction Models for the Design of Alkylhydrazide-Based HDAC3 Inhibitors as Novel Anti-Cancer Compounds
Emre F Bülbül, Dina Robaa, Ping Sun, et al.
ACS Chemical Neuroscience
|
November 11, 2024
Aromatic Amino Acid Hydroxylases as Off-Targets of Histone Deacetylase Inhibitors
Anne Baumann, Niklas Papenkordt, Dina Robaa, et al.
Chemmedchem
|
September 17, 2016
Identification and Structure-Activity Relationship Studies of Small-Molecule Inhibitors of the Methyllysine Reader Protein Spindlin1
Dina Robaa, Tobias Wagner, Chiara Luise, et al.
Journal of Medicinal Chemistry
|
July 18, 2015
Enantiomerically Pure 2-Methyltetrahydro-3-benzazepin-1-ols Selectively Blocking GluN2B Subunit Containing N-Methyl-D-aspartate Receptors
Bastian Tewes, Bastian Frehland, Dirk Schepmann, et al.
Archiv Der Pharmazie
|
July 12, 2024
Utilization of an optimized AlphaFold protein model for structure-based design of a selective HDAC11 inhibitor with anti-neuroblastoma activity
Fady Baselious, Sebastian Hilscher, Sven Hagemann, et al.
European Journal of Medicinal Chemistry
|
February 20, 2020
Negative allosteric modulators of the GluN2B NMDA receptor with phenylethylamine structure embedded in ring-expanded and ring-contracted scaffolds
Louisa Temme, Elena Bechthold, Julian A Schreiber, et al.
Journal of Medicinal Chemistry
|
September 6, 2011
Chiral indolo[3,2-f][3]benzazecine-type dopamine receptor antagonists: synthesis and activity of racemic and enantiopure derivatives
Dina Robaa, Christoph Enzensperger, Shams Eldin Abulazm, et al.
Page
of 8
Search research articles
Search
Showing results (31-40 of 75) with videos related to
Sort By:
Page
of 8
Journal of Medicinal Chemistry
|
February 26, 2010
Dopamine receptor ligands. Part 18: (1) modification of the structural skeleton of indolobenzazecine-type dopamine receptor antagonists
Dina Robaa, Christoph Enzensperger, Shams El Din Abul Azm, et al.
Molecules (Basel, Switzerland)
|
April 30, 2021
Binding Free Energy (BFE) Calculations and Quantitative Structure-Activity Relationship (QSAR) Analysis of <i>Schistosoma mansoni</i> Histone Deacetylase 8 (<i>sm</i>HDAC8) Inhibitors
Conrad V Simoben, Ehab Ghazy, Patrik Zeyen, et al.
Molecules (Basel, Switzerland)
|
February 13, 2025
Synthesis and Antimycobacterial Assays of Some New Ethambutol Analogs
Rana Abdelaziz, Mthandazo Dube, Lea Mann, et al.
Pharmaceuticals (Basel, Switzerland)
|
July 29, 2023
Application of Ligand- and Structure-Based Prediction Models for the Design of Alkylhydrazide-Based HDAC3 Inhibitors as Novel Anti-Cancer Compounds
Emre F Bülbül, Dina Robaa, Ping Sun, et al.
ACS Chemical Neuroscience
|
November 11, 2024
Aromatic Amino Acid Hydroxylases as Off-Targets of Histone Deacetylase Inhibitors
Anne Baumann, Niklas Papenkordt, Dina Robaa, et al.
Chemmedchem
|
September 17, 2016
Identification and Structure-Activity Relationship Studies of Small-Molecule Inhibitors of the Methyllysine Reader Protein Spindlin1
Dina Robaa, Tobias Wagner, Chiara Luise, et al.
Journal of Medicinal Chemistry
|
July 18, 2015
Enantiomerically Pure 2-Methyltetrahydro-3-benzazepin-1-ols Selectively Blocking GluN2B Subunit Containing N-Methyl-D-aspartate Receptors
Bastian Tewes, Bastian Frehland, Dirk Schepmann, et al.
Archiv Der Pharmazie
|
July 12, 2024
Utilization of an optimized AlphaFold protein model for structure-based design of a selective HDAC11 inhibitor with anti-neuroblastoma activity
Fady Baselious, Sebastian Hilscher, Sven Hagemann, et al.
European Journal of Medicinal Chemistry
|
February 20, 2020
Negative allosteric modulators of the GluN2B NMDA receptor with phenylethylamine structure embedded in ring-expanded and ring-contracted scaffolds
Louisa Temme, Elena Bechthold, Julian A Schreiber, et al.
Journal of Medicinal Chemistry
|
September 6, 2011
Chiral indolo[3,2-f][3]benzazecine-type dopamine receptor antagonists: synthesis and activity of racemic and enantiopure derivatives
Dina Robaa, Christoph Enzensperger, Shams Eldin Abulazm, et al.
Page
of 8